IL1B and Alzheimer disease: Since it is known that activation of IFN receptors induce pro-inflammatory cytokines, including expression of TNF-α and IL-1β [1], it is natural to assume that IFN signaling plays a critical role in regulating immune response in DS, and may serve as accelerators of AD neuropathogenesis in DS.